Our Symposia attract hundreds of unique individuals, who are leading researchers, physicians, clinicians, stakeholders, advocates and social workers with the common goal of finding better treatment, and ultimately, a cure for sickle cell disease. Our attendees also originate from every corner of the world, with our highest numbers originating from the United States and U.S. Territories, the United Kingdom, Canada, Ghana, Sierra Leone, France, Italy, Switzerland, Brazil, Uruguay, Jamaica, Haiti and India.

Due to the COVID-19 pandemic, all meetings are held virtually until further notice. We are doing this for the safety of our precious patient population and all those that interact with them.

For information about submitting an abstract or manuscript for our Journal of Sickle Cell Disease and Hemoglobinopathies, such as due dates and fees, please click here.